KIN14K Antibody

Shipped with Ice Packs
In Stock

Description

Clarification of Terminology

The term "KIN14K" does not align with established antibody nomenclature or kinase-related antibody targets in the literature. It may represent:

  • A typographical error: Possible confusion with "KIN001," a combination therapy (pamapimod + pioglitazone) investigated in a phase 2 COVID-19 trial .

  • A novel compound: If "KIN14K" refers to an emerging antibody, no peer-reviewed data or commercial listings exist in the provided sources.

Related Antibodies and Kinase Targets

While "KIN14K Antibody" is not documented, several antibodies targeting kinases or potassium channels are described in the search results:

Antibody/CompoundTargetKey DetailsSource
Anti-Kir2.1 (N112B/14)Kir2.1 (KCNJ2) potassium channelMonoclonal IgG1; used in ICC, IHC, WB; no cross-reactivity with Kir2.2/2.3
Anti-KIT mAbKIT receptor tyrosine kinaseEnhances antitumor activity of checkpoint inhibitors; reduces MDSCs
KIN001Synergistic antiviral/anti-inflammatory therapyPamapimod + pioglitazone; no significant clinical efficacy in COVID-19 trial
Anti-Kir4.1 (APC-035)Kir4.1 (KCNJ10) potassium channelReacts with rat, mouse, human; validated in IHC/WB

Critical Observations

  • No matches for "KIN14K Antibody": The search results focus on antibodies targeting potassium channels (Kir2.1, Kir4.1), KIT, or keratins, but none mention "KIN14K."

  • Potential kinase misattribution: If "KIN14K" refers to a kinase inhibitor, no antibody-based therapies are described in the provided data.

Recommendations for Further Investigation

  1. Verify nomenclature: Confirm the correct name of the antibody or target protein.

  2. Explore kinase-related antibodies: Review antibodies targeting kinases (e.g., TBK1/NAK; source ) or potassium channels (e.g., Kir2.1, Kir4.1).

  3. Consult updated databases: Use platforms like PubMed, ClinicalTrials.gov, or antibody vendor catalogs (e.g., Alomone, R&D Systems) for real-time data.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
KIN14K antibody; At5g41310 antibody; K1O13.11Kinesin-like protein KIN-14K antibody
Target Names
KIN14K
Uniprot No.

Q&A

What is KIN14K and why is it significant in research?

KIN14K (also known as kinesin-4) is a motor protein belonging to the kinesin superfamily found in Oryza sativa Japonica Group (Japanese rice). It functions as part of the cellular transport machinery, playing important roles in intracellular trafficking, cell division, and cytoskeletal organization. The gene is identified by Entrez Gene ID 4339353 and has synonyms including OsJ_19246 . Studying KIN14K provides insights into fundamental cellular processes in plants, particularly related to microtubule-based transport systems and cellular architecture.

What types of KIN14K antibodies are available for research?

While specific commercial antibodies for KIN14K were not detailed in the search results, researchers typically have access to both polyclonal and monoclonal antibodies for kinesin proteins. Polyclonal antibodies offer broader epitope recognition, while monoclonal antibodies provide higher specificity for particular epitopes. For novel proteins like KIN14K, custom antibody development may be necessary, following similar approaches to those used for other kinesin family members or techniques demonstrated in studies like the C11C1 monoclonal antibody development for high-molecular weight kininogen .

How should KIN14K antibodies be validated before experimental use?

Validation of KIN14K antibodies should follow a multi-step process:

  • Western blot analysis to confirm specificity for the target protein (expected molecular weight of KIN14K)

  • Immunoprecipitation to verify antibody-antigen binding

  • Immunohistochemistry or immunofluorescence to confirm appropriate cellular localization

  • Blocking peptide controls to demonstrate specificity

  • Testing in knockout/knockdown systems where available

  • Cross-reactivity testing against related kinesin family members

Similar to validation approaches used for antibodies like C11C1, researchers should ensure the antibody binds to the intended target without non-specific binding .

What is the optimal protocol for immunohistochemistry using KIN14K antibodies in plant tissues?

When performing immunohistochemistry with KIN14K antibodies in plant tissues, researchers should follow this optimized protocol:

  • Fix plant tissue samples in 4% paraformaldehyde for 24 hours

  • Perform paraffin embedding and sectioning (5-8 μm thickness)

  • Deparaffinize sections and perform antigen retrieval using citrate buffer (pH 6.0)

  • Block with 5% normal serum in PBS with 0.3% Triton X-100

  • Incubate with primary KIN14K antibody (1:100-1:500 dilution range, optimized per antibody)

  • Apply secondary antibody conjugated to biotin or fluorophore

  • For colorimetric detection, use avidin-biotin immunoperoxidase complex similar to methods described for other antibody studies

  • Counterstain, dehydrate, and mount sections

  • Include positive controls (tissues known to express KIN14K) and negative controls (primary antibody omitted)

The protocol should be optimized based on specific antibody characteristics and plant tissue type.

How can Western blotting protocols be optimized for KIN14K detection?

For optimal Western blot detection of KIN14K:

  • Extract total protein from plant tissues using a buffer containing protease inhibitors

  • Separate proteins on 8-10% SDS-PAGE gels (kinesins are typically large proteins)

  • Transfer to PVDF membrane (preferable for higher molecular weight proteins)

  • Block with 5% non-fat dry milk in TBST

  • Incubate with KIN14K primary antibody (1:1000 suggested starting dilution)

  • Use HRP-conjugated secondary antibody and enhanced chemiluminescence detection

  • Expected band size for KIN14K should correspond to predicted molecular weight derived from protein sequence data (XP_015639474.1, XP_015639475.1)

  • Include positive and negative controls

For challenging detections, consider using gradient gels and optimizing transfer conditions for high molecular weight proteins.

What are the recommended storage conditions for maintaining KIN14K antibody activity?

To maintain optimal KIN14K antibody activity:

  • Store concentrated antibody stocks at -20°C to -80°C in small aliquots to avoid freeze-thaw cycles

  • Working dilutions can be stored at 4°C with preservatives (0.02% sodium azide) for 1-2 weeks

  • Monitor antibody performance regularly using positive controls

  • Avoid exposure to light for fluorophore-conjugated antibodies

  • Follow manufacturer's specific storage recommendations based on antibody formulation

  • Record lot numbers and validation data to track performance over time

Proper storage is critical for maintaining consistent results across experiments, particularly for quantitative analyses.

How can KIN14K antibodies be used to study protein-protein interactions in plant motor complexes?

KIN14K antibodies can be valuable tools for studying protein-protein interactions through:

  • Co-immunoprecipitation (Co-IP):

    • Lyse plant cells under non-denaturing conditions

    • Incubate lysates with KIN14K antibody

    • Capture complexes with Protein A/G beads

    • Analyze precipitated proteins by mass spectrometry or Western blotting

  • Proximity Ligation Assay (PLA):

    • Use KIN14K antibody in combination with antibodies against suspected interaction partners

    • Detect protein proximity (<40 nm) through rolling circle amplification

    • Quantify interaction signals microscopically

  • Chromatin Immunoprecipitation (ChIP) (if relevant):

    • If KIN14K has nuclear functions, ChIP can identify DNA binding regions

    • Follow standard ChIP protocols with validated KIN14K antibodies

These approaches can reveal novel interactions and functional relationships between KIN14K and other cellular components in kinesin-mediated transport processes.

What strategies can overcome cross-reactivity issues when studying closely related kinesin family members?

When studying KIN14K among related kinesin family members:

  • Epitope selection:

    • Design antibodies against unique regions of KIN14K protein sequence

    • Target divergent domains rather than conserved motor domains

    • Compare sequences of KIN14K isoforms (X1, X2) to identify variant-specific regions

  • Pre-adsorption controls:

    • Pre-incubate antibody with related kinesin proteins

    • Compare staining patterns before and after pre-adsorption

  • Knockout/knockdown validation:

    • Test antibody specificity in tissues with reduced KIN14K expression

    • Confirm signal reduction proportional to expression level

  • Multiple antibody approach:

    • Use antibodies targeting different KIN14K epitopes

    • Confirm consistent localization/interaction patterns

  • Bioinformatic analysis:

    • Perform comprehensive sequence alignment of rice kinesin family

    • Identify unique sequence regions suitable for specific antibody generation

These strategies help ensure experimental findings are genuinely KIN14K-specific rather than reflecting related kinesin activities.

How can super-resolution microscopy be combined with KIN14K immunolabeling to study subcellular transport mechanisms?

Combining super-resolution microscopy with KIN14K immunolabeling:

  • Sample preparation:

    • Fix cells with methods optimized for structural preservation

    • Use smaller probes (Fab fragments, nanobodies) for better resolution

    • Consider dual-color labeling with microtubule markers

  • Techniques selection:

    • STED microscopy: Provides 30-80 nm resolution for co-localization studies

    • STORM/PALM: Achieve 10-20 nm resolution for detailed protein distribution

    • Expansion microscopy: Physical expansion of samples for conventional microscopes

  • Quantitative analysis:

    • Track individual KIN14K-labeled structures

    • Measure co-localization with cargo markers

    • Analyze directional movement in live cell imaging

    • Quantify cluster sizes and distributions

  • Controls:

    • Include cytoskeletal disruption controls

    • Compare wild-type vs. mutant kinesin distributions

    • Use both N- and C-terminal labeling approaches when possible

This approach can reveal KIN14K's precise localization relative to cellular structures and potential cargo, providing insights into its transport functions in plant cells.

How can non-specific background be reduced in KIN14K immunostaining of plant tissues?

To reduce non-specific background in KIN14K immunostaining:

  • Optimize blocking:

    • Test different blocking agents (BSA, normal serum, casein, commercial blockers)

    • Increase blocking time (2-16 hours) at 4°C

    • Include 0.1-0.3% Triton X-100 or Tween-20 in blocking solution

  • Improve antibody conditions:

    • Titrate antibody concentration to optimal signal-to-noise ratio

    • Increase washing steps (number and duration)

    • Consider overnight incubation at 4°C instead of shorter incubations

  • Tissue-specific optimizations:

    • For highly autofluorescent plant tissues, use Sudan Black B (0.1-0.3%)

    • Consider spectral unmixing during image acquisition

    • Use specific plant tissue clearing protocols before immunostaining

  • Antibody purification:

    • Consider pre-adsorption against plant tissue lysates

    • Use affinity-purified antibodies when available

These approaches parallel techniques used in antibody studies like those for C11C1, where specificity must be carefully controlled .

What controls are essential when publishing research using KIN14K antibodies?

Essential controls for KIN14K antibody research publications:

  • Antibody validation controls:

    • Western blot showing single band of expected molecular weight

    • Peptide competition/blocking controls

    • Knockout/knockdown validation where available

    • Immunoprecipitation followed by mass spectrometry confirmation

  • Experimental controls:

    • No primary antibody control

    • Isotype-matched control antibody (for monoclonals)

    • Pre-immune serum control (for polyclonals)

    • Positive control tissue known to express KIN14K

    • Negative control tissue with minimal KIN14K expression

  • Quantification controls:

    • Blinded analysis of images/results

    • Technical and biological replicates (minimum n=3)

    • Statistical analysis appropriate to data distribution

    • Standardized exposure/acquisition parameters

  • Reporting requirements:

    • Complete antibody information (source, catalog number, RRID, lot)

    • Detailed methods including dilutions, incubation times, and temperatures

    • Raw data availability statement

Similar standards should be applied as demonstrated in immunohistochemistry studies using antibodies like C11C1, where rigorous controls were employed .

How can quantitative image analysis be used to measure KIN14K expression levels across different plant tissues?

For quantitative analysis of KIN14K expression across plant tissues:

  • Sample preparation standardization:

    • Process all tissues simultaneously using identical protocols

    • Include internal calibration standards on each slide/batch

    • Use consistent fixation times and antibody concentrations

  • Image acquisition parameters:

    • Maintain identical exposure settings, gain, and offset values

    • Capture images below saturation

    • Use identical objective and zoom settings

    • Include multiple random fields per sample (n≥5)

  • Quantification approaches:

    • Measure integrated density of KIN14K signal

    • Normalize to tissue area or cell number

    • Consider ratio to housekeeping protein control

    • Use automated thresholding algorithms for consistency

  • Statistical analysis:

    • Compare multiple tissues using appropriate statistical tests

    • Report mean, standard deviation, and sample size

    • Consider hierarchical analysis for nested data

  • Data presentation:

    • Present results in standardized tables with tissue types and expression levels

    • Include representative images alongside quantification

This approach allows for robust comparison of KIN14K expression patterns that can be correlated with tissue-specific functions.

How do KIN14K protein levels correlate with gene expression data in plant development studies?

When correlating KIN14K protein levels with gene expression:

  • Experimental design:

    • Collect matched samples for protein and RNA analysis

    • Sample across developmental stages or treatments

    • Include multiple biological replicates

  • Methods comparison:

    • Quantify KIN14K protein by Western blot densitometry or ELISA

    • Measure mRNA expression by qRT-PCR or RNA-seq

    • Normalize protein data to loading controls (e.g., actin)

    • Normalize mRNA data to reference genes

  • Correlation analysis:

    • Calculate Pearson or Spearman correlation coefficients

    • Perform time-lag analysis for protein translation delays

    • Consider non-linear relationships

  • Data integration:

    • Create integrated visualization of protein and mRNA levels

    • Analyze discrepancies for potential post-transcriptional regulation

    • Consider protein half-life and stability factors

This approach can reveal regulatory mechanisms controlling KIN14K expression and potential post-transcriptional regulation affecting protein abundance relative to mRNA levels.

What are the approaches to distinguish between different KIN14K isoforms in experimental samples?

To distinguish between KIN14K isoforms:

TechniqueApplicationResolutionConsiderations
Isoform-specific antibodiesWestern blot, IHC, IPHigh specificity for targeted epitopesRequires unique epitope sequences between isoforms
RT-PCR with isoform-specific primersmRNA detectionCan distinguish splice variantsDoes not confirm protein expression
2D gel electrophoresisProtein separation by pI and MWCan separate similar proteins with post-translational modificationsLabor-intensive, requires optimization
Mass spectrometryPeptide identificationHigh resolution, can identify unique peptidesRequires sophisticated equipment and analysis
RNA-seqTranscript identificationComprehensive view of all expressed isoformsInformatics-intensive, does not confirm protein

Based on the search results, KIN14K has multiple isoforms including X1 and X2 variants (XP_015639474.1, XP_015639475.1) . Isoform-specific detection requires careful design of antibodies or primers targeting unique regions in each variant. Mass spectrometry-based proteomics offers the most definitive approach for distinguishing protein isoforms by identifying unique peptide sequences.

How can KIN14K antibodies be used in plant stress response studies?

For studying KIN14K in plant stress responses:

  • Stress treatment experimental design:

    • Apply standardized stress conditions (drought, salt, temperature, pathogens)

    • Sample at multiple time points (early, middle, late responses)

    • Include appropriate non-stressed controls

  • Analytical approaches:

    • Immunoblotting to quantify total KIN14K protein changes

    • Immunofluorescence to examine subcellular redistribution

    • Co-IP to identify stress-specific interaction partners

    • Fractionation studies to assess cytoskeletal association changes

  • Functional correlations:

    • Combine with cytoskeletal visualization

    • Track organelle movement under stress

    • Correlate KIN14K changes with physiological responses

    • Compare wild-type vs. stress-resistant varieties

  • System-level integration:

    • Relate KIN14K changes to other molecular stress responses

    • Consider post-translational modifications under stress

    • Examine transcriptional vs. translational regulation

This approach can reveal how KIN14K contributes to cellular adaptations under stress conditions, potentially illuminating mechanisms of stress tolerance in crop plants.

What methodological considerations are important when using KIN14K antibodies in immunoprecipitation for identifying interaction partners?

For successful KIN14K immunoprecipitation:

  • Lysis conditions optimization:

    • Test different buffers (RIPA, NP-40, digitonin-based)

    • Include protease and phosphatase inhibitors

    • Optimize salt concentration to maintain interactions

    • Consider crosslinking for transient interactions

  • Antibody selection and validation:

    • Verify IP efficiency with Western blot

    • Compare different antibody clones if available

    • Consider epitope tag approaches if endogenous IP is challenging

    • Test antibody orientation (direct coupling vs. protein A/G capture)

  • Controls design:

    • IgG control matching antibody species/isotype

    • Input sample preservation

    • Unrelated protein IP as specificity control

    • Reciprocal IP when possible

  • Downstream analysis options:

    • Mass spectrometry for unbiased interaction discovery

    • Targeted Western blot for suspected partners

    • Activity assays for functional verification

    • Structural studies of purified complexes

Careful optimization of these parameters will enhance the specificity and yield of KIN14K interaction studies, potentially revealing novel components of motor protein complexes in plants.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.